Arthritis drug helps with severe coronavirus Arthritis drug baricitinib reduces the risk of patients with severe coronavirus dying from the effects of the disease. These are the results of a study by scientists from the University of Oxford.

Arthritis drug cuts risk of death in most severe coronavirus patients by up to 20%. The level of protection can be compared to that of dexamethasone and tocilizumab, drugs that have already proven their ability to save the lives of those infected.. A study by Oxford scientists involved 8,000 hospitalized victims of covid, and according to its results, doctors may have another weapon at their disposal in the fight against the insidious virus.

During the experiments, all patients received the standard recommended treatment, but half were also given baricitinib tablets once a day for 10 days.. There were 33 fewer deaths in this group compared to those who received only standard treatment.. Thus, the risk of death was reduced by 13%, but scientists believe that the true figure could be as high as 20%..

The most valuable thing is that the drug baricitinib is already approved for use, it has long gone through the necessary clinical studies, though not for the treatment of covid.. Therefore, it can be quickly introduced into clinical practice.. The drug was approved 5 years ago to treat rheumatoid arthritis, a condition in which an overreacting immune system attacks the joints.. In severe forms of coronavirus, there is also an overreaction of the immune system or a cytokine storm..

https://www. medicalforum. en/.

Keywords:.